Immunology
Showing page 43 of 174 pages of list content
-
De novo design of high-affinity antibody variable regions (Fv) against the SARS-CoV-2 spike protein
This article's authors -
Classical drug digitoxin inhibits influenza cytokine storm, with implications for COVID-19 therapy
This article's authors -
Currently available intravenous immunoglobulin (Gamunex ® -C and Flebogamma ® DIF) contains antibodies reacting against SARS-CoV-2 antigens
This article's authors -
Analysis of the SARS-CoV-2 spike protein glycan shield: implications for immune recognition
This article's authors -
JAK1 inhibition blocks lethal sterile immune responses: implications for COVID-19 therapy
This article's authors -
Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue
This article's authors -
Energetics based epitope screening in SARS CoV-2 (COVID 19) spike glycoprotein by Immuno-informatic analysis aiming to a suitable vaccine development
This article's authors -
A SARS-CoV-2 Vaccination Strategy Focused on Population-Scale Immunity
This article's authors -
Scrutinizing the SARS-CoV-2 protein information for the designing an effective vaccine encompassing both the T-cell and B-cell epitopes
This article's authors -
Prioritization of SARS-CoV-2 epitopes using a pan-HLA and global population inference approach
This article's authors